يعرض 1 - 20 نتائج من 100 نتيجة بحث عن '"Francis Varaine"', وقت الاستعلام: 0.65s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
  15. 15
  16. 16
  17. 17

    المساهمون: Médecins Sans Frontières [Paris] (MSF), Centre d'Immunologie et de Maladies Infectieuses (CIMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Centre National de Référence des Mycobactéries et de la Résistance aux Antituberculeux [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institute of Tropical Medicine [Antwerp] (ITM), Epicentre [Paris] [Médecins Sans Frontières], Harvard Medical School [Boston] (HMS), University of Cape Town, Médecins Sans Frontières [Cape Town, South Africa], Unité de Recherche Clinique [CHU Pitié-Salpêtrière], Abiomed SARL, Société Abiomed, National AIDS Research Institute, Indian Council of Medical Research [New Dehli] (ICMR), Brigham & Women’s Hospital [Boston] (BWH), The indus hospital [Karachi, Pakistan], Dana-Farber Cancer Institute [Boston], Harvard T.H. Chan School of Public Health, Groote Schuur Hospital, University of Cape Town, South Africa., Beth Israel Deaconess Medical Center [Boston] (BIDMC), Centre for Infectious Disease Epidemiology and Research (CIDER), Faculty of Health Sciences, Centre d'Immunologie et des Maladies Infectieuses (CIMI), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Recherches Translationnelles sur le VIH et les maladies infectieuses endémiques et émergentes (TransVIHMI), Institut de Recherche pour le Développement (IRD)-Université de Yaoundé I-Université Cheikh Anta Diop [Dakar, Sénégal] (UCAD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Centre d'investigation clinique Paris Est [CHU Pitié Salpêtrière] (CIC Paris-Est), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), The trial and the preparation of this manuscript are funded by a grantprovided by Unitaid. The funding source had no role in the study design, inthe collection, management, analysis, or interpretation of data, in the writingof the report, or in the decision to submit the report for publication.GEV received funding from the National Institute of Allergy and InfectiousDiseases at the US National Institutes of Health (grant numbers K08AI141740, L30 AI120170, and P30 AI060354), the Dr. Lynne Reid/Drs. Eleanorand Miles Shore Fellowship at Harvard Medical School, the Burke GlobalHealth Fellowship at the Harvard Global Health Institute, and the HarvardUniversity Center for AIDS Research

    المصدر: Trials, vol 22, iss 1
    Trials
    Trials, BioMed Central, 2021, 22 (1), pp.651. ⟨10.1186/s13063-021-05491-3⟩
    Trials, Vol 22, Iss 1, Pp 1-15 (2021)
    Trials, 2021, 22 (1), pp.651. ⟨10.1186/s13063-021-05491-3⟩

    مصطلحات موضوعية: Medicine (General), Bedaquiline, Antitubercular Agents, Medicine (miscellaneous), Rifampin-resistant tuberculosis, Cardiorespiratory Medicine and Haematology, Clofazimine, law.invention, Non-inferiority, Study Protocol, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, Fluoroquinolone, law, Tuberculosis, Multidrug-Resistant, Medicine, Pharmacology (medical), Lung, Randomized Controlled Trials as Topic, Bayesian adaptive randomization, 0303 health sciences, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences, Multidrug-Resistant, 3. Good health, Infectious Diseases, Pharmaceutical Preparations, 6.1 Pharmaceuticals, Delamanid, Rifampin, Infection, medicine.drug, Treatment shortening, medicine.medical_specialty, Randomization, Tuberculosis, MESH: Bayes Theorem, MESH: Pharmaceutical Preparations, Clinical Trials and Supportive Activities, Clinical Sciences, MDR-TB, Vaccine Related, 03 medical and health sciences, R5-920, Rare Diseases, Clinical Research, Internal medicine, Biodefense, General & Internal Medicine, Humans, Adverse effect, MESH: Tuberculosis, Multidrug-Resistant, MESH: Humans, 030306 microbiology, business.industry, Prevention, Linezolid, Evaluation of treatments and therapeutic interventions, Bayes Theorem, medicine.disease, MESH: Antitubercular Agents, MESH: Rifampin, Pyrazinamide, Clinical trial, Regimen, MESH: Randomized Controlled Trials as Topic, Emerging Infectious Diseases, Orphan Drug, 030228 respiratory system, chemistry, Cardiovascular System & Hematology, Rifampicin-resistant tuberculosis, Antimicrobial Resistance, business

    وصف الملف: application/pdf

  18. 18
  19. 19

    المصدر: Antimicrobial Agents and Chemotherapy
    Antimicrobial agents and chemotherapy

  20. 20